Analyst consensus rating
Ginkgo Bioworks Holdings Analyst Rating: none
DNA is rated none by 2 analysts with a $7.00 target. As of 2026-08-30.
Direct answer
Ginkgo Bioworks Holdings's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.00.
Forecast evidence checked August 30, 2026.
Get free Ginkgo Bioworks Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.96
- Average price target
- $7.00
- High price target
- $9.00
- Low price target
- $5.00
- Low target gap
- -28.2%
- Target upside
- +0.6%
- High target gap
- +29.3%
- Target range width
- 57.5%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- August 30, 2026
- Valid through
- September 6, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings has a verified none consensus. The same dataset has an average price target of $7.00.
How far are Ginkgo Bioworks Holdings's low and high targets from the recorded price?
The low target implies -28.2%, while the high target implies +29.3%.
How many analysts are included in Ginkgo Bioworks Holdings's consensus?
The verified consensus includes 2 analysts.
How is Ginkgo Bioworks Holdings's target upside or downside calculated?
The average target of $7.00 is divided by the recorded price of $6.96, then one is subtracted to produce +0.6%. This does not guarantee a future return.
When was Ginkgo Bioworks Holdings's analyst forecast verified?
The data was verified on 2026-08-30. The dataset is valid through 2026-09-06.